Effects of chronic fluoxetine in animal models of anxiety and depression

被引:523
作者
Dulawa, SC
Hollick, KA
Gundersen, B
Hen, R
机构
[1] Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA
[2] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA
[3] Columbia Univ, Dept Psychiat, New York, NY 10032 USA
关键词
BALB/c; forced swim test; novelty-induced hypophagia; open field; antidepressants;
D O I
10.1038/sj.npp.1300433
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The onset of the therapeutic response to antidepressant treatment exhibits a characteristic delay. Animal models sensitive to chronic, but not acute, antidepressant treatment are greatly needed for studying antidepressant mechanisms. We initially assessed four inbred mouse strains for their behavioral response to chronic treatment with the selective-serotonin reuptake inhibitor fluoxetine (0, 5, 10 mg/kg/day in drinking water), which is used for the treatment of mood and anxiety disorders, Only the highly anxious BALB/c strain exhibited sensitivity to fluoxetine in the forced swim test. Additionally, fluoxetine reduced locomotion in C57BL/6 and 129SvEv, but not BALB/c and DBA/2, strains. We then evaluated the effects of subchronic (similar to4 days) and chronic (similar to24 days) fluoxetine treatment (0, 10, 18, 25 mg/kg/day) on measures of anxiety and depression in BALB/c mice. Anxiety measures were obtained using the open field and novelty-induced hypophagia tests. Antidepressant effects were evaluated using the forced swim test. We found 18 mg/kg/day of chronic fluoxetine to be active in all three paradigms; subchronic treatment had no effect, Anxiety-related measures were reduced by 18 mg/kg/day. In the forced swim test, 10 and 18 mg/kg/day increased swimming and reduced immobility. Here we present several novel effects of chronic, but not subchronic, antidepressant treatment.
引用
收藏
页码:1321 / 1330
页数:10
相关论文
共 51 条
  • [1] Genotype- and experience-dependent susceptibility to depressive-like responses in the forced-swimming test
    Alcaro, A
    Cabib, S
    Ventura, R
    Puglisi-Allegra, S
    [J]. PSYCHOPHARMACOLOGY, 2002, 164 (02) : 138 - 143
  • [2] A 'crash' course on psychostimulant withdrawal as a model of depression
    Barr, AM
    Markou, A
    Phillips, AG
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (10) : 475 - 482
  • [3] Effects of fluoxetine administration on mood response to tryptophan depletion in healthy subjects
    Barr, LC
    Heninger, GR
    Goodman, W
    Charney, DS
    Price, LH
    [J]. BIOLOGICAL PSYCHIATRY, 1997, 41 (09) : 949 - 954
  • [4] COMPARISON OF DIFFERENT BEHAVIORAL-TEST SITUATIONS USED IN PSYCHOPHARMACOLOGY FOR MEASUREMENT OF ANXIETY
    BELZUNG, C
    LEPAPE, G
    [J]. PHYSIOLOGY & BEHAVIOR, 1994, 56 (03) : 623 - 628
  • [5] Bilkei-Gorzo A, 2002, J NEUROSCI, V22, P10046
  • [6] The pharmacology of putative early-onset antidepressant strategies
    Blier, P
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 (02) : 57 - 66
  • [7] BODNOFF SR, 1988, PSYCHOPHARMACOLOGY, V95, P298
  • [8] Do animal models of anxiety predict anxiolytic-like effects of antidepressants?
    Borsini, F
    Podhorna, J
    Marazziti, D
    [J]. PSYCHOPHARMACOLOGY, 2002, 163 (02) : 121 - 141
  • [9] DISCOVERY OF ANTIDEPRESSANT ACTIVITY BY FORCED SWIMMING TEST MAY DEPEND ON PRE-EXPOSURE OF RATS TO A STRESSFUL SITUATION
    BORSINI, F
    LECCI, A
    SESSAREGO, A
    FRASSINE, R
    MELI, A
    [J]. PSYCHOPHARMACOLOGY, 1989, 97 (02) : 183 - 188
  • [10] How valuable are animal models in defining antidepressant activity?
    Bourin, M
    Fiocco, AJ
    Clenet, F
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2001, 16 (01) : 9 - 21